Tenon Medical (NASDAQ:TNON – Free Report) had its price target trimmed by Benchmark from $5.00 to $3.00 in a research report sent to investors on Monday morning, Benzinga reports. The firm currently has a speculative buy rating on the stock.
Tenon Medical Price Performance
Shares of NASDAQ:TNON opened at $0.77 on Monday. The company has a market capitalization of $2.87 million, a price-to-earnings ratio of -0.08 and a beta of 2.24. The firm’s 50 day simple moving average is $1.07 and its 200 day simple moving average is $1.23. Tenon Medical has a fifty-two week low of $0.71 and a fifty-two week high of $23.00.
Tenon Medical (NASDAQ:TNON – Get Free Report) last announced its earnings results on Tuesday, March 12th. The company reported ($0.68) EPS for the quarter. The company had revenue of $0.81 million for the quarter. Tenon Medical had a negative return on equity of 934.11% and a negative net margin of 532.14%.
Hedge Funds Weigh In On Tenon Medical
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints.
Recommended Stories
- Five stocks we like better than Tenon Medical
- CD Calculator: Certificate of Deposit Calculator
- United Airlines Soars on Earnings Beat
- How to Most Effectively Use the MarketBeat Earnings Screener
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Why Invest in High-Yield Dividend Stocks?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.